$66.3 K

BPTH Mkt cap, 28-Jan-2019
Bio-Path Holdings Net income (Q2, 2019)-2.5 M
Bio-Path Holdings EBIT (Q2, 2019)-2.5 M
Bio-Path Holdings Cash, 30-Jun-201917.1 M

Bio-Path Holdings Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

13.0k37.0k

R&D expense

1.5m1.6m3.0m5.5m5.5m4.6m

General and administrative expense

1.2m986.1k1.6m2.7m2.5m3.0m3.5m3.4m

Operating expense total

2.4m2.6m3.3m4.5m5.5m8.5m9.0m8.6m

EBIT

(2.4m)(2.6m)(3.3m)(4.5m)(5.5m)(8.5m)(9.0m)(8.6m)

EBIT margin, %

(65192%)(24232%)

Interest expense

2.3k1.7m1.9m7.0k

Interest income

2.9k779.04.0k22.6k17.7k12.0k9.0k7.0k

Pre tax profit

(2.4m)(2.6m)(3.3m)(4.5m)(5.5m)(6.7m)(7.0m)(8.6m)

Income tax expense

Net Income

(2.4m)(2.6m)(3.3m)(4.5m)(5.5m)(6.7m)(7.0m)(8.6m)

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

R&D expense

107.6k517.0k424.5k592.5k564.4k992.4k1.0m1.2m2.3m1.0m1.5m1.6m932.0k827.0k2.3m398.0k1.5m

General and administrative expense

324.6k327.4k231.3k252.2k246.1k239.8k810.2k380.9k754.5k713.4k786.4k566.6k519.9k849.0k757.0k681.0k970.0k845.0k893.0k987.0k852.0k740.0k1.1m966.0k

Operating expense total

463.8k504.5k522.6k787.8k840.5k655.9k1.4m510.2k1.3m1.2m1.4m1.1m1.5m1.9m1.9m3.0m2.0m2.3m2.5m1.9m1.7m3.1m1.5m2.5m

EBIT

(463.8k)(504.5k)(522.6k)(787.8k)(840.5k)(655.9k)(1.4m)(510.2k)(1.3m)(1.2m)(1.4m)(1.1m)(1.5m)(1.9m)(1.9m)(3.0m)(2.0m)(2.3m)(2.5m)(1.9m)(1.7m)(3.1m)(1.5m)(2.5m)

Interest expense

1.0k670.0400.056.063.0521.06.0k5.7k4.3k5.4k4.8k2.0k2.0k1.4m1.6m340.0k2.0k3.0k2.0k1.0k8.0k33.0k

Interest income

1.1k870.0529.0213.026.0124.0837.05.6k6.1k5.7k4.3k5.4k4.8k2.0k2.0k4.0k3.0k2.0k2.0k3.0k2.0k1.0k8.0k33.0k

Pre tax profit

(522.2k)

Net Income

(462.7k)(503.8k)(522.2k)(787.8k)(840.6k)(656.0k)(1.4m)(504.9k)(1.3m)(1.1m)(1.4m)(1.1m)(1.5m)(1.9m)(1.9m)(1.6m)(397.0k)(2.0m)(2.5m)(1.9m)(1.7m)(3.1m)(1.5m)(2.5m)

Bio-Path Holdings Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

952.3k534.0k3.6m13.9m8.9m9.4m6.0m1.0m

Accounts Receivable

Prepaid Expenses

48.4k42.6k64.1k100.5k179.0k1.1m332.0k

Inventories

Current Assets

1.2m771.6k3.7m14.1m9.6m10.7m7.4m1.9m

PP&E

113.1k72.0k614.0k654.0k406.0k

Total Assets

3.2m2.3m5.1m15.5m10.8m12.2m8.9m2.3m

Accounts Payable

121.5k57.0k76.1k41.0k54.6k69.0k52.0k813.0k

Short-term debt

791.5k928.2k1.1m1.2m1.4m1.7m

Current Liabilities

316.1k329.2k294.9k562.0k937.4k1.1m791.0k1.1m

Long-term debt

Total Debt

791.5k1.7m

Total Liabilities

316.1k329.2k294.9k562.0k937.4k4.0m791.0k1.1m

Common Stock

58.3k62.2k84.2k89.8k89.8k11.0k1.0k

Preferred Stock

Additional Paid-in Capital

12.4m13.3m20.1m34.7m35.1m40.3m47.2m49.0m

Retained Earnings

(25.4m)(32.1m)(39.2m)(47.7m)

Total Equity

2.9m2.0m4.8m14.9m9.8m8.2m8.1m1.2m

Financial Leverage

1.1 x1.2 x1.1 x1 x1.1 x1.5 x1.1 x1.9 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

1.2m983.3k576.8k162.4k332.9k288.7k1.9m4.1m16.8m15.7m14.6m12.5m11.1m9.9m6.5m4.2m11.3m7.1m6.2m4.6m4.3m2.6m2.3m19.3m17.1m

Prepaid Expenses

45.1k52.0k56.3k46.5k45.4k53.9k46.4k49.7k157.5k171.6k194.2k122.6k253.6k200.8k750.0k1.3m196.0k377.0k592.0k653.0k1.3m1.3m257.0k427.0k654.0k

Current Assets

1.3m1.0m654.2k504.4k457.8k438.6k2.3m4.3m17.2m16.0m14.9m12.9m12.0m10.5m7.8m6.1m12.4m8.4m7.8m5.8m5.9m4.5m2.8m20.9m18.6m

PP&E

102.8k92.6k82.3k62.0k51.0k66.0k872.0k797.0k720.0k605.0k539.0k473.0k340.0k307.0k

Total Assets

3.7m3.4m2.7m2.2m2.1m2.0m3.7m5.8m18.6m17.4m16.3m14.2m13.3m11.7m8.9m7.1m13.4m10.1m9.4m7.3m7.2m5.7m3.9m21.3m19.3m

Accounts Payable

24.2k43.1k58.4k31.1k65.4k71.9k165.9k43.6k238.0k78.9k88.5k76.6k385.1k127.1k201.0k123.0k118.0k89.0k96.0k121.0k136.0k137.0k451.0k607.0k444.0k

Short-term debt

684.2k737.2k839.6k839.6k(888.1k)968.4k1.0m1.0m1.1m1.2m1.2m1.3m1.3m1.4m1.5m1.5m1.5m1.6m1.7m1.7m1.8m1.8m1.9m

Current Liabilities

220.7k205.0k246.6k243.0k268.6k290.4k267.9k173.8k420.0k333.5k283.2k616.2k692.2k481.2k900.0k813.0k866.0k709.0k576.0k767.0k929.0k1.0m957.0k1.1m1.0m

Long-term debt

Total Debt

684.2k737.2k839.6k839.6k(888.1k)1.5m1.5m1.5m1.6m1.7m1.7m1.8m1.8m1.9m

Total Liabilities

220.7k205.0k246.6k243.0k268.6k290.4k267.9k173.8k420.0k333.5k283.2k616.2k692.2k481.2k900.0k813.0k4.1m2.0m576.0k767.0k929.0k1.0m957.0k1.2m1.4m

Common Stock

56.1k56.1k58.5k58.9k58.9k62.2k75.4k75.4k89.2k89.2k89.2k89.8k89.8k89.8k90.0k90.0k96.0k96.0k100.0k100.0k11.0k11.0k13.0k3.0k3.0k

Preferred Stock

Additional Paid-in Capital

11.6m11.7m12.5m12.6m12.5m13.3m16.6m16.9m34.0m34.1m34.2m34.8m34.9m35.0m35.2m35.4m40.0m40.5m43.3m43.4m47.3m47.5m48.8m69.4m69.6m

Retained Earnings

(22.4m)(23.9m)(27.3m)(29.2m)(30.8m)(32.5m)(34.5m)(37.0m)(41.1m)(42.7m)(45.8m)(49.3m)(51.7m)

Total Equity

3.4m3.2m2.5m1.9m1.8m1.7m3.5m5.6m18.2m17.0m16.0m13.6m12.6m11.2m8.0m6.3m9.4m8.1m8.9m6.5m6.3m4.7m3.0m20.1m17.9m

Financial Leverage

1.1 x1.1 x1.1 x1.1 x1.1 x1.2 x1.1 x1 x1 x1 x1 x1 x1.1 x1 x1.1 x1.1 x1.4 x1.2 x1.1 x1.1 x1.1 x1.2 x1.3 x1.1 x1.1 x

Bio-Path Holdings Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(2.4m)(2.6m)(3.3m)(4.5m)(5.5m)(6.7m)(7.0m)(8.6m)

Depreciation and Amortization

928.2k1.1m10.3k41.1k43.0k251.0k265.0k

Accounts Receivable

244.5k

Inventories

(64.6k)42.0k143.6k(103.3k)(404.8k)

Accounts Payable

69.4k13.1k(34.3k)267.1k375.4k(146.0k)326.0k

Cash From Operating Activities

(1.1m)(2.0m)(2.3m)(3.8m)(5.0m)(8.1m)(8.0m)(6.1m)

Purchases of PP&E

(123.4k)(338.0k)(538.0k)(17.0k)

Cash From Investing Activities

(170.1k)(25.0k)(123.4k)(338.0k)(538.0k)(17.0k)

Cash From Financing Activities

2.0m1.6m5.3m14.2m9.0m5.1m1.2m

Net Change in Cash

713.7k(418.2k)3.0m10.3m(5.0m)521.0k(3.4m)(5.0m)

Interest Paid

Income Taxes Paid

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(1.1m)(1.6m)(522.2k)(1.3m)(2.2m)(656.0k)(1.1m)(2.5m)(504.9k)(1.8m)(2.9m)(1.4m)(2.5m)(4.0m)(1.9m)(3.8m)(5.4m)(397.0k)(2.4m)(4.9m)(1.9m)(3.6m)(6.7m)(1.5m)(4.0m)

Depreciation and Amortization

10.3k20.6k30.9k10.0k21.0k31.0k33.0k108.0k185.0k66.0k132.0k198.0k66.0k99.0k

Accounts Receivable

244.5k244.5k

Inventories

88.4k88.4k132.0k(142.5k)73.5k(99.0k)(84.2k)46.7k(197.7k)(90.0k)(45.2k)(204.2k)(541.2k)(249.7k)(51.0k)(19.0k)

Accounts Payable

(26.0k)(41.8k)(69.5k)(73.1k)(47.6k)(38.8k)(61.4k)(155.5k)125.1k38.6k(11.7k)54.3k130.2k(80.7k)(37.0k)(124.0k)(71.0k)(208.0k)(257.0k)(36.0k)138.0k214.0k166.0k(54.0k)(328.0k)

Cash From Operating Activities

(375.6k)(726.2k)(400.2k)(1.0m)(1.6m)(551.0k)(1.1m)(1.8m)(544.4k)(1.6m)(2.7m)(1.4m)(2.8m)(4.0m)(2.4m)(4.6m)(6.5m)(1.8m)(4.2m)(5.7m)(1.7m)(3.4m)(4.8m)(2.0m)(4.2m)

Purchases of PP&E

(66.1k)(25.0k)(424.0k)(538.0k)(538.0k)(17.0k)(17.0k)(17.0k)

Cash From Investing Activities

(37.5k)(62.5k)(25.0k)(25.0k)(25.0k)(66.1k)(25.0k)(424.0k)(538.0k)(538.0k)(17.0k)(17.0k)(17.0k)

Cash From Financing Activities

1.4m1.5m49.8k264.7k973.1k305.7k2.5m5.4m13.8m13.8m13.8m9.0m1.5m1.5m1.2m20.3m20.3m

Net Change in Cash

983.1k744.7k(375.4k)(789.8k)(619.4k)(245.3k)1.4m3.6m13.3m12.2m11.1m(1.4m)(2.8m)(4.0m)(2.4m)(4.6m)2.4m(2.3m)(3.2m)(4.8m)(1.7m)(3.4m)(3.7m)18.3m16.1m

Interest Paid

Income Taxes Paid

Bio-Path Holdings Ratios

USDY, 2019

Financial Leverage

1.1 x